Chapter/Section Purchase

1 Surgical Skin Antiseptic Market Overview
1.1 Product Overview and Scope of Surgical Skin Antiseptic
1.2 Surgical Skin Antiseptic Segment by Type
1.2.1 Global Surgical Skin Antiseptic Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Alcohols
1.2.3 Chlorhexidine
1.2.4 Iodine
1.2.5 Octenidine
1.2.6 Others
1.3 Surgical Skin Antiseptic Segment by Application
1.3.1 Global Surgical Skin Antiseptic Sales Comparison by Application: (2022-2028)
1.3.2 Surgeries
1.3.3 Injections
1.3.4 Others
1.4 Global Surgical Skin Antiseptic Market Size Estimates and Forecasts
1.4.1 Global Surgical Skin Antiseptic Revenue 2017-2028
1.4.2 Global Surgical Skin Antiseptic Sales 2017-2028
1.4.3 Surgical Skin Antiseptic Market Size by Region: 2017 Versus 2021 Versus 2028
2 Surgical Skin Antiseptic Market Competition by Manufacturers
2.1 Global Surgical Skin Antiseptic Sales Market Share by Manufacturers (2017-2022)
2.2 Global Surgical Skin Antiseptic Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Surgical Skin Antiseptic Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Surgical Skin Antiseptic Manufacturing Sites, Area Served, Product Type
2.5 Surgical Skin Antiseptic Market Competitive Situation and Trends
2.5.1 Surgical Skin Antiseptic Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Surgical Skin Antiseptic Players Market Share by Revenue
2.5.3 Global Surgical Skin Antiseptic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Surgical Skin Antiseptic Retrospective Market Scenario by Region
3.1 Global Surgical Skin Antiseptic Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Surgical Skin Antiseptic Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Surgical Skin Antiseptic Market Facts & Figures by Country
3.3.1 North America Surgical Skin Antiseptic Sales by Country
3.3.2 North America Surgical Skin Antiseptic Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Surgical Skin Antiseptic Market Facts & Figures by Country
3.4.1 Europe Surgical Skin Antiseptic Sales by Country
3.4.2 Europe Surgical Skin Antiseptic Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Surgical Skin Antiseptic Market Facts & Figures by Region
3.5.1 Asia Pacific Surgical Skin Antiseptic Sales by Region
3.5.2 Asia Pacific Surgical Skin Antiseptic Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Surgical Skin Antiseptic Market Facts & Figures by Country
3.6.1 Latin America Surgical Skin Antiseptic Sales by Country
3.6.2 Latin America Surgical Skin Antiseptic Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Surgical Skin Antiseptic Market Facts & Figures by Country
3.7.1 Middle East and Africa Surgical Skin Antiseptic Sales by Country
3.7.2 Middle East and Africa Surgical Skin Antiseptic Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Surgical Skin Antiseptic Historic Market Analysis by Type
4.1 Global Surgical Skin Antiseptic Sales Market Share by Type (2017-2022)
4.2 Global Surgical Skin Antiseptic Revenue Market Share by Type (2017-2022)
4.3 Global Surgical Skin Antiseptic Price by Type (2017-2022)
5 Global Surgical Skin Antiseptic Historic Market Analysis by Application
5.1 Global Surgical Skin Antiseptic Sales Market Share by Application (2017-2022)
5.2 Global Surgical Skin Antiseptic Revenue Market Share by Application (2017-2022)
5.3 Global Surgical Skin Antiseptic Price by Application (2017-2022)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.1.4 3M Surgical Skin Antiseptic Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.2.4 BD Surgical Skin Antiseptic Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Johnson & Johnson Services
6.3.1 Johnson & Johnson Services Corporation Information
6.3.2 Johnson & Johnson Services Description and Business Overview
6.3.3 Johnson & Johnson Services Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Johnson & Johnson Services Surgical Skin Antiseptic Product Portfolio
6.3.5 Johnson & Johnson Services Recent Developments/Updates
6.4 Reckitt Benckiser
6.4.1 Reckitt Benckiser Corporation Information
6.4.2 Reckitt Benckiser Description and Business Overview
6.4.3 Reckitt Benckiser Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Reckitt Benckiser Surgical Skin Antiseptic Product Portfolio
6.4.5 Reckitt Benckiser Recent Developments/Updates
6.5 B. Braun Melsungen
6.5.1 B. Braun Melsungen Corporation Information
6.5.2 B. Braun Melsungen Description and Business Overview
6.5.3 B. Braun Melsungen Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.5.4 B. Braun Melsungen Surgical Skin Antiseptic Product Portfolio
6.5.5 B. Braun Melsungen Recent Developments/Updates
6.6 Purdue Pharma
6.6.1 Purdue Pharma Corporation Information
6.6.2 Purdue Pharma Description and Business Overview
6.6.3 Purdue Pharma Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Purdue Pharma Surgical Skin Antiseptic Product Portfolio
6.6.5 Purdue Pharma Recent Developments/Updates
6.7 EcoLab
6.6.1 EcoLab Corporation Information
6.6.2 EcoLab Description and Business Overview
6.6.3 EcoLab Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.4.4 EcoLab Surgical Skin Antiseptic Product Portfolio
6.7.5 EcoLab Recent Developments/Updates
6.8 Sch?lke & Mayr GmbH
6.8.1 Sch?lke & Mayr GmbH Corporation Information
6.8.2 Sch?lke & Mayr GmbH Description and Business Overview
6.8.3 Sch?lke & Mayr GmbH Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sch?lke & Mayr GmbH Surgical Skin Antiseptic Product Portfolio
6.8.5 Sch?lke & Mayr GmbH Recent Developments/Updates
6.9 PSK Pharma
6.9.1 PSK Pharma Corporation Information
6.9.2 PSK Pharma Description and Business Overview
6.9.3 PSK Pharma Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.9.4 PSK Pharma Surgical Skin Antiseptic Product Portfolio
6.9.5 PSK Pharma Recent Developments/Updates
6.10 Kimberly-Clark
6.10.1 Kimberly-Clark Corporation Information
6.10.2 Kimberly-Clark Description and Business Overview
6.10.3 Kimberly-Clark Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Kimberly-Clark Surgical Skin Antiseptic Product Portfolio
6.10.5 Kimberly-Clark Recent Developments/Updates
6.11 Sirmaxo Chemicals
6.11.1 Sirmaxo Chemicals Corporation Information
6.11.2 Sirmaxo Chemicals Surgical Skin Antiseptic Description and Business Overview
6.11.3 Sirmaxo Chemicals Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Sirmaxo Chemicals Surgical Skin Antiseptic Product Portfolio
6.11.5 Sirmaxo Chemicals Recent Developments/Updates
6.12 Avrio Health
6.12.1 Avrio Health Corporation Information
6.12.2 Avrio Health Surgical Skin Antiseptic Description and Business Overview
6.12.3 Avrio Health Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Avrio Health Surgical Skin Antiseptic Product Portfolio
6.12.5 Avrio Health Recent Developments/Updates
6.13 Sage Products LLC
6.13.1 Sage Products LLC Corporation Information
6.13.2 Sage Products LLC Surgical Skin Antiseptic Description and Business Overview
6.13.3 Sage Products LLC Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Sage Products LLC Surgical Skin Antiseptic Product Portfolio
6.13.5 Sage Products LLC Recent Developments/Updates
6.14 Walgreen Co.
6.14.1 Walgreen Co. Corporation Information
6.14.2 Walgreen Co. Surgical Skin Antiseptic Description and Business Overview
6.14.3 Walgreen Co. Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Walgreen Co. Surgical Skin Antiseptic Product Portfolio
6.14.5 Walgreen Co. Recent Developments/Updates
6.15 CVS Health
6.15.1 CVS Health Corporation Information
6.15.2 CVS Health Surgical Skin Antiseptic Description and Business Overview
6.15.3 CVS Health Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.15.4 CVS Health Surgical Skin Antiseptic Product Portfolio
6.15.5 CVS Health Recent Developments/Updates
6.16 M?lnlycke Health Care
6.16.1 M?lnlycke Health Care Corporation Information
6.16.2 M?lnlycke Health Care Surgical Skin Antiseptic Description and Business Overview
6.16.3 M?lnlycke Health Care Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.16.4 M?lnlycke Health Care Surgical Skin Antiseptic Product Portfolio
6.16.5 M?lnlycke Health Care Recent Developments/Updates
6.17 MPM Medical, Inc.
6.17.1 MPM Medical, Inc. Corporation Information
6.17.2 MPM Medical, Inc. Surgical Skin Antiseptic Description and Business Overview
6.17.3 MPM Medical, Inc. Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.17.4 MPM Medical, Inc. Surgical Skin Antiseptic Product Portfolio
6.17.5 MPM Medical, Inc. Recent Developments/Updates
6.18 Lagaay International
6.18.1 Lagaay International Corporation Information
6.18.2 Lagaay International Surgical Skin Antiseptic Description and Business Overview
6.18.3 Lagaay International Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Lagaay International Surgical Skin Antiseptic Product Portfolio
6.18.5 Lagaay International Recent Developments/Updates
6.19 Cardinal Health
6.19.1 Cardinal Health Corporation Information
6.19.2 Cardinal Health Surgical Skin Antiseptic Description and Business Overview
6.19.3 Cardinal Health Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Cardinal Health Surgical Skin Antiseptic Product Portfolio
6.19.5 Cardinal Health Recent Developments/Updates
6.20 Smith & Nephew
6.20.1 Smith & Nephew Corporation Information
6.20.2 Smith & Nephew Surgical Skin Antiseptic Description and Business Overview
6.20.3 Smith & Nephew Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Smith & Nephew Surgical Skin Antiseptic Product Portfolio
6.20.5 Smith & Nephew Recent Developments/Updates
6.21 Microgen
6.21.1 Microgen Corporation Information
6.21.2 Microgen Surgical Skin Antiseptic Description and Business Overview
6.21.3 Microgen Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Microgen Surgical Skin Antiseptic Product Portfolio
6.21.5 Microgen Recent Developments/Updates
7 Surgical Skin Antiseptic Manufacturing Cost Analysis
7.1 Surgical Skin Antiseptic Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Surgical Skin Antiseptic
7.4 Surgical Skin Antiseptic Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Surgical Skin Antiseptic Distributors List
8.3 Surgical Skin Antiseptic Customers
9 Surgical Skin Antiseptic Market Dynamics
9.1 Surgical Skin Antiseptic Industry Trends
9.2 Surgical Skin Antiseptic Market Drivers
9.3 Surgical Skin Antiseptic Market Challenges
9.4 Surgical Skin Antiseptic Market Restraints
10 Global Market Forecast
10.1 Surgical Skin Antiseptic Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Surgical Skin Antiseptic by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Surgical Skin Antiseptic by Type (2023-2028)
10.2 Surgical Skin Antiseptic Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Surgical Skin Antiseptic by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Surgical Skin Antiseptic by Application (2023-2028)
10.3 Surgical Skin Antiseptic Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Surgical Skin Antiseptic by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Surgical Skin Antiseptic by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer